Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-085676
Filing Date
2025-06-12
Accepted
2025-06-12 18:34:31
Documents
2
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3824
2 EX-24.POA bdtx-ex24_poa.htm EX-24.POA 29876
  Complete submission text file 0000950170-25-085676.txt   35211
Mailing Address 2855 SAND HILL ROAD MENLO PARK CA 94025
Business Address
Behbahani Ali (Reporting) CIK: 0001613867 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 251044220

Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)